Malignant mast cell neoplasm

Also known as: Malignant Mast Cell Tumors / Mast Cell Leukemia (MCL) / Leukemia, Mast Cell / Mast Cell Leukemia / Malignant-mast cell tumours / Mast-Cell Sarcoma

DrugDrug NameDrug Description
DB06595MidostaurinAn antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL).
DrugDrug NamePhaseStatusCount
DB15233Avapritinib1Active Not Recruiting1
DB01268Sunitinib1Completed1
DB00091Cyclosporine1 / 2Completed1
DB01073Fludarabine1 / 2Completed1
DB00688Mycophenolate mofetil1 / 2Completed1
DB00087Alemtuzumab2Active Not Recruiting1
DB15233Avapritinib2Recruiting1
DB08870Brentuximab vedotin2Completed1
DB00091Cyclosporine2Active Not Recruiting1
DB01609Deferasirox2Completed1
DB01073Fludarabine2Active Not Recruiting1
DB09053Ibrutinib2Terminated1
DB06595Midostaurin2Completed1
DB00688Mycophenolate mofetil2Active Not Recruiting1
DB01268Sunitinib2Terminated1
DB00091CyclosporineNot AvailableCompleted2
DB01073FludarabineNot AvailableCompleted2
DB00529FoscarnetNot AvailableCompleted1
DB01004GanciclovirNot AvailableCompleted1
DB00688Mycophenolate mofetilNot AvailableCompleted2
DB01610ValganciclovirNot AvailableCompleted1